Transfusion Evidence Round-Up World Blood Donor Day June 14, 2023
Introduction
Welcome to the quarterly Transfusion Evidence Round-Up. This is a collaboration between the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL). We aim to highlight high quality evidence randomised controlled trials and systematic reviews about an internationally relevant subject in the field of Transfusion Medicine. All references are drawn from the Transfusion Evidence Library and, where relevant, Stem Cell Evidence.
This Transfusion Evidence Round-Up is sent to ISBT members and TEL subscribers, so if you are a subscriber to both mailing lists and receive it twice please bear with us until we can resolve this. If you are not an ISBT member yet but would like to become one to continue receiving these emails you can sign-up here.
The Transfusion Evidence Library is produced by the Systematic Review Initiative (SRI) and funded by the four UK blood services. It is available free at the point of access providing a comprehensive and up-to-date database of high-quality evidence in Transfusion Medicine.
The International Society of Blood Transfusion (ISBT) is a scientific society creating a community of transfusion medicine professionals from around the globe. ISBT works towards its vision of "a world of safe and sufficient blood" by undertaking advocacy for patient and donor safety, sharing knowledge to enhance transfusion practice and providing opportunities for education.
Top 10 articles
Ten articles are highlighted to bring attention to World Blood Donor Day 2023.
These articles have been identified from the Transfusion Evidence Library and selected by ISBT members: Karin Magnussen, Jessica Guglielmino and Nour Al-Mozain.
Top article
High-dose intravenous versus oral iron in blood donors with iron deficiency: the IronWoMan randomized, controlled clinical trial.
Selected articles
These articles will be discussed during the workshop in Gothenburg.
High-dose intravenous versus oral iron in blood donors with iron deficiency: the IronWoMan randomized, controlled clinical trial. Drexler, C., et al. (2020). Clinical Nutrition.
Donor deferral due to low hemoglobin – an updated systematic review.
Browne, A., et al. (2019). Transfusion Medicine Reviews.
A systematic review of interventions used to increase blood donor compliance with deferral criteria. Cutts, J.C., et al. (2021). Transfusion Medicine and Hemotherapy.
Promoting awareness of donation-related iron depletion among high risk blood donors.
France, J.L., et al. (2021). Transfusion
Effect of plasma and blood donations on levels of perfluoroalkyl and polyfluoroalkyl substances in firefighters in Australia: a randomized clinical trial.
Gasiorowski, R., et al. (2022). JAMA Network Open.
Notifying donors when their deferral is ending: an effective donor retention strategy.
Gemelli, C.N., et al. (2021). Transfusion.
Improving donor retention following a temporary deferral: A cluster randomized controlled trial of deferral educational materials.
Gemelli, C.N., et al. (2022). Transfusion.
Improving the donation experience and reducing venipuncture pain by addressing fears among whole-blood and plasma donors.
Gilchrist, P.T., et al. (2021). Transfusion.
The benefits of iron supplementation following blood donation vary with baseline iron status.
Mast, A.E., et al. (2020). American Journal of Hematology.
Bringing new plasma donors back: testing the efficacy of telephone and e-mail communications with first-time donors.
Thorpe, R., et al. (2020). Transfusion.
Editorial Board
Jessica Guglielmino
Jessica Guglielmino is a blood bank and haematology medical scientist at Monash Medical Centre in Melbourne, Australia. Graduated with a Masters of Laboratory Medicine from RMIT University, she is passionate about all aspects of immunohematology and transfusion science. She is also a research scientist within Monash University’s Transfusion Research Unit (TRU). Jess is an active member in numerous professional societies, including the International Society of Blood Transfusion (ISBT), the Australian & New Zealand Society of Blood Transfusion (ANZSBT) and the Australian Institute of Medical and Clinical Scientists (AIMS).
Nour Almozain
Nour is Haematopatgology and Transfusion Medicine Physician at King Faisal Specialist Hospital & Research Center. Her passion for transfusion medicine started by realizing the profound interaction between basic science, laboratory medicine, and clinical practice.
It is an opportunity to learn a new thing every day. You are not only required to identify what went right and what went wrong. However, you will constantly be stimulated to determine further what could be done better and forecast a better practice for the future. Adding to all of that, the are not many doctors around the world who are encouraged to have this as a specialty, so she decided to have it as her career to provide patient care uniquely and differently. Besides, she is a big advocate for this specialty among the younger generation.
Systematic Research Initiative
The Systematic Review Initiative (SRI) is a clinical research group established in 2001 by NHS Blood and Transplant (NHSBT) and funded by the UK Blood Services. The primary objective of the SRI is to “develop the evidence base for the practice of transfusion medicine”, by undertaking systematic reviews and other evidence-based medicine research projects in the transfusion field. @sritransfusion
- Twitter:
- @sritransfusion
Transfusion Evidence Library
- Twitter:
- @transfusionlib
Stem Cell Evidence
Stem Cell Evidence is a comprehensive collection of high quality research relevant to haematopoietic stem cell transplantation, updated monthly. The most important articles in the field are highlighted in the Stem Cell Evidence Alert which is a newsletter emailed to subscribers. Stem Cell Evidence aims to be a key resource worldwide for medical practitioners, clinical researchers and policy makers. It is also intended to be of value to those planning new clinical trials in the field. It is produced by the Systematic Review Initiative and funded by the UK Blood Services and Oxford Biomedical Research Centre.
- Twitter:
- @evidencestemc
